Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Chronic renal failure (CRF) threatens human health greatly and attracts worldwide concerns of health professionals in the public health sector. In our preliminary study, we found that Compound capsule (Shengqing Jiangzhuo Capsule, SQJZJN) had a significant therapeutic effect on CRF. Quercetin is one of the main components of this Compound capsule. In this study, we investigated the effect of Quercetin monomer on CRF and the regulation of PI3k/Akt pathway. Network pharmacology analysis methods were employed to analyze the SQJZJN/Quercetin/PIK3R1 network relationships. In this study, a CRF rat model was prepared using the gavage adenine solution method and detected the indicators of Creatinine (Cr), Blood Urea Nitrogen (BUN), and Uric Acid (UA). After treating the rat model with Quercetin and PIK3R1-interfering lentivirus, respectively, we observed the changes on the histological morphology of the kidney and detected apoptosis using TUNEL staining. Gene and protein expression associated with renal function were detected using qPCR, WB and immunofluorescence. Quercetin was identified as the main ingredient of SQJZJN by the network pharmacological screening and Quercetin at 1.5 and 3 g/(kg.d) concentrations could effectively alleviate the CRF symptoms, reduce the levels of Cr, BUN, and UA, and markedly inhibit cell apoptosis demonstrated by the intragastric administration. Furthermore, the protein expression of p-PI3K, p-AKT, NLRP3, caspase1, AQP1, and AQP2 in all groups was detected by immunofluorescence and western blot assays, indicating that Quercetin could reduce the expression of NLRP3, caspase1, p-PI3k, and p-Akt, and increase the expression of AQP1 and AQP2 in the renal tissues of CRF rats. Being labeled with biotin and incubated with the total protein extracted from kidney tissues, Quercetin could bind to PIK3R1. Following the PIK3R1 interference lentivirus was injected into the CRF model rats by tail vein, the CRF symptoms were effectively alleviated in the PIK3R1 interference group, consistent with the effect of Quercetin. Taken together, Quercetin, a major component of SQJZJN, might minimize renal fibrosis and apoptosis in CRF rats by inhibiting the PI3k/Akt pathway through targeting PIK3R1. By regulating AQP1 and AQP2, both water retention and toxin accumulation were reduced.

          ABSTRACT

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          Emerging roles of aerobic glycolysis in breast cancer

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK

            It has been long recognized that cancer cells reprogram their metabolism under hypoxia conditions due to a shift from oxidative phosphorylation (OXPHOS) to glycolysis in order to meet elevated requirements in energy and nutrients for proliferation, migration, and survival. However, data accumulated over recent years has increasingly provided evidence that cancer cells can revert from glycolysis to OXPHOS and maintain both reprogrammed and oxidative metabolism, even in the same tumor. This phenomenon, denoted as cancer cell metabolic plasticity or hybrid metabolism, depends on a tumor micro-environment that is highly heterogeneous and influenced by an intensity of vasculature and blood flow, oxygen concentration, and nutrient and energy supply, and requires regulatory interplay between multiple oncogenes, transcription factors, growth factors, and reactive oxygen species (ROS), among others. Hypoxia-inducible factor-1 (HIF-1) and AMP-activated protein kinase (AMPK) represent key modulators of a switch between reprogrammed and oxidative metabolism. The present review focuses on cross-talks between HIF-1, glucose transporters (GLUTs), and AMPK with other regulatory proteins including oncogenes such as c-Myc, p53, and KRAS; growth factor-initiated protein kinase B (PKB)/Akt, phosphatidyl-3-kinase (PI3K), and mTOR signaling pathways; and tumor suppressors such as liver kinase B1 (LKB1) and TSC1 in controlling cancer cell metabolism. The multiple switches between metabolic pathways can underlie chemo-resistance to conventional anti-cancer therapy and should be taken into account in choosing molecular targets to discover novel anti-cancer drugs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Progression of chronic kidney disease: too much cellular talk causes damage.

              Tubulointerstitial fibrosis, tubular atrophy, and peritubular capillary rarefaction are major hallmarks of chronic kidney disease. The tubulointerstitium consists of multiple cell components including tubular epithelial, mesenchymal (fibroblasts and pericytes), endothelial, and inflammatory cells. Crosstalk among these cell components is a key component in the pathogenesis of this complex disease. After severe or recurrent injury, the renal tubular epithelial cells undergo changes in structure and cell cycle that are accompanied by altered expression and production of cytokines. These cytokines contribute to the initiation of the fibrotic response by favoring activation of fibroblasts, recruitment of inflammatory cells, and loss of endothelial cells. This review focuses on how augmented growth factor and cytokine production induces epithelial crosstalk with cells in the interstitium to promote progressive tubulointerstitial fibrosis after renal injury.
                Bookmark

                Author and article information

                Journal
                Bioengineered
                Bioengineered
                Bioengineered
                Taylor & Francis
                2165-5979
                2165-5987
                16 September 2021
                2021
                16 September 2021
                : 12
                : 1
                : 6538-6558
                Affiliations
                [a ]Division of Nephrology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine; , Guangdong, Guangzhou, China
                [b ]Science and Technology Innovation Center, Guangzhou University of Chinese Medicine; , Guangdong, Guangzhou, China
                [c ]Department of Intensive Care Unit, The First Affiliated Hospital of Guangzhou University of Chinese Medicine; , Guangzhou, Guangdong, China
                [d ]Division of Nephrology, Chongqing Hospital of Traditional Chinese Medicine; , Chongqing, China
                [e ]Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine; , Guangzhou, Guangdong, China
                [f ]Department of Endocrinology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine; , Guangzhou, Guangdong, China
                [g ]Department of Rehabilitation Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine; , Guangzhou, Guangdong, China
                Author notes
                CONTACT Shuifu Tang tangshuifu18@ 123456163.com Division of Nephrology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou; , Guangdong, China
                Ying Li sabrina_pipi@ 123456163.com Division of Nephrology, Chongqing Hospital of Traditional Chinese Medicine; , Chongqing, China
                Article
                1973877
                10.1080/21655979.2021.1973877
                8806539
                34528858
                71ddc061-68de-4d56-8a8d-13699a86205f
                © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Figures: 13, References: 40, Pages: 21
                Categories
                Research Article
                Research Paper

                Biomedical engineering
                crf,quercetin,pik3r1,pi3k/akt
                Biomedical engineering
                crf, quercetin, pik3r1, pi3k/akt

                Comments

                Comment on this article